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In this work, principal component analysis and cluster analysis were applied as helping tools to extract 
useful information in the development of formulations and manufacturing processes of melt granulates. 
Two melt granulation processes that differ in the shear stress applied to the solid bed during melting step 
were designed. These processes employ equipment frequently used in the local pharmaceutical industry. 
The selected binders include both hydrophilic and hydrophobic excipients, which were used alone or in 
binary mixtures. Granulates were characterized regarding their physicomechanical properties, including 
their compaction behavior. The resulting tablets were also evaluated. The selected multivariate statistical 
methods proved to be useful in facilitating the interpretation of the collected data and the study of the 
properties of granulates and tablets, as well as the selection of more efficient production processes.
Uniterms: Granulates/evaluation. Tablets/evaluation. Granulates/manufacturing processes. Melt 
granulates/manufacturing processes. Tablets/production processes. Principal component analysis/
application. Cluster analysis/application. Pharmaceutical formulations/development. Melt granulation/
application.
Neste trabalho, foram aplicadas as técnicas de análise de componentes principais e de análise de 
agrupamentos para extrair informações úteis no desenvolvimento de formulações e de processos de 
produção de granulados por fusão. Desenharam-se dois processos de granulação por fusão que apresentam 
diferenças na tensão de cisalhamento aplicada ao leito sólido durante a etapa de fusão. Esses processos 
empregam equipamentos frequentemente usados na indústria farmacêutica local. Os ligantes escolhidos 
incluíram excipientes tanto hidrofílicos quanto hidrofóbicos, utilizados de forma individual ou em misturas 
binárias. Os granulados foram caracterizados quanto às suas propriedades físico-mecânicas, incluindo 
seu desempenho no processo de compactação. Os comprimidos resultantes também foram avaliados. 
Os métodos de análise multivariada escolhidos provaram ser úteis para facilitar a interpretação dos 
dados coletados e o estudo das propriedades dos granulados e dos comprimidos, bem como a seleção 
de processos de produção mais eficientes.
Unitermos: Granulados/avaliação. Comprimidos/avaliação. Granulados/processo de manufaturação. 
Granulados por fusão/processo de manufaturação. Comprimidos/processo de produção. Análise 
de componentes principais/aplicação. Análise de cluster/aplicação. Formulações farmacêuticas/
desenvolvimento. Granulação por fusão/aplicação. 
INTRODUCTION
Granulation continues to be an extensively practiced 
process in the pharmaceutical industry. Melt granulation 
allows the elimination of procedures such as wetting and 
drying, which leads to a reduction in process time and cost. 
In this process, agglomeration is achieved by the addition 
of a meltable binder that is solid at room temperature and 
can be added at solid or molten state (Seo, Schæfer, 2001). 
Melt granulation offers other advantages, such as few 
process parameters to control during process scale-up and 
validation and greater patient/industry safety, as well as less 
environmental risks by avoiding the use of organic solvents 
(Thies, Kleinebudde, 1999). Moreover, by selecting a sui-
table binder, immediate or modified release formulations 
can be prepared (Thomsen, Schæfer, Kristensen, 1994; 
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Passerini et al., 2002). The processes discussed in interna-
tional literature mainly focus on the use of high shear mixers 
(Thies, Kleinebudde, 1999; Perissutti et al., 2003), extruders 
(Perissutti et al., 2002), and fluid bed granulators (Kidoko-
ro et al., 2002), since these equipments have shown to be 
efficient in melt granulation. Unlike other studies, in the 
present work, two melt granulation processes that employ 
equipment still frequently used in the local pharmaceutical 
industry, such as drying ovens and medium shear jacketed 
mixers, were designed. These processes differ in the shear 
stress applied to the solid bed during the melting step. One 
process imposes movement of medium shear stress on the 
solid bed (moving bed process), while the other does not 
impose movement at all on the solid bed (static bed process).
Generally, several different pharmacotechnical tests 
are employed in the evaluation of granulates and of the 
tablets obtained after their compaction. As a result of the 
difficulties encountered in handling the great amount of data 
obtained from these pharmacotechnical tests, the benefit of 
employing tools which make this task easier becomes cle-
arly evident and has been previously reported in literature 
(Gabrielsson et al., 2003; Otsuka, Mouri, Matsuda, 2003). 
When a number of samples are described by many varia-
bles, the variables tend to be correlated to some extent. By 
applying principal component analysis (PCA) to a data set, 
the relevant information is extracted in a few principal com-
ponents, making representation and interpretation easier 
(Gabrielsson et al., 2003; Piggot, 1986). Meanwhile, cluster 
analysis (CA) seek to divide a set of samples characterized 
by a series of variables into several groups or clusters so 
that samples within the same cluster are more similar to 
each other than samples in different clusters. However, it is 
not always necessary that all samples belonging to a cluster 
be similar to each other. Instead, it is necessary that these 
samples present a high connectivity among them. More 
dissimilar samples belonging to the same cluster can be 
joined by a chain of nearest samples (Almeida et al., 2007). 
Despite the fact that these techniques have proved to be 
useful in different contexts, they are not much popular in 
pharmacotechnical studies.
 In this context, the aim of the present study was 
to evaluate melt granulates using multivariate statistical 
tools such as PCA and CA.
MATERIALS AND METHODS
Materials
The selected meltable binders include both hydro-
philic and hydrophobic excipients, which were used alone 
or in binary mixtures, such as: polyethylene glycol (PEG) 
6000, povidone (PVP) K30, glyceryl palmitostearate 
(GPS), stearic acid ( STA) and glyceryl monostearate 
(GMS). These excipients were selected regarding the 
melting temperature range (45-100 ºC) recommended as 
adequate for melt granulation (Thomsen, Schæfer, Kris-
tensen, 1994), as well as regarding water affinity, safety, 
and low cost. PVP, though it melts over 150 ºC, is soluble 
in molten PEG and thus can also contribute to melt gra-
nulation. The solid materials to be granulated were corn 
starch, carbamazepine (anticonvulsivant drug, CBZ), 
ketoprofen (analgesic, anti-inflammatory drug, KP), and 
lactose monohydrate. Sodium croscarmellose (SCC), 
magnesium stearate and talc were used as adjuvants for 
the tablet formulations obtained from granulates.
The compositions of formulated granulates are 
shown in Table I.
Methods
Granulation processes
·	 Moving bed process. The solid material to be gra-
nulated and the binder are sieved through a 0.5 mm 
sieve. Solids are mixed for 15 minutes in a tumbling 
mixer (Turbula, Bachofen, Switzerland). The gra-
nulation is carried out by raising the temperature of 
the solid mixture in a laboratory scale mixer with 
electrical heating jacket and impeller (Erweka, 
SG 2, Germany), operating at 65 ºC ± 5 ºC and 
90 r.p.m. ± 5 r.p.m. for 15 to 20 minutes. The agglo-
merated mass is transferred to a glass tray, where 
it is kept until room temperature is reached. The 
granulate particle size is calibrated by an oscillating 
granulator through a 1 mm screen.
·	 Static bed process. As in the previous process and 
under the same operative conditions, the solid ma-
terial to be granulated and the binder are sieved and 
mixed. The granulation is carried out by raising the 
temperature of the solid mixture in a drying oven 
(Memmert, Germany) at 70 °C ± 3 °C during 1 hour 
(the mixture is placed in a glass tray obtaining a dep-
th bed of approximately 2 cm). The bed is kept in the 
same container until room temperature is reached. 
The granulate particle size is calibrated by manual 
sieving through a 1 mm sieve.
As PEG, STA, and GMS were purchased as flakes, 
they had to be milled (cutting mill, 0.5 mm sieve) before 
the preparation of the granulates obtained using any of 
the two processes.
Pharmacotechnical characterization of the granulates
Particle size distributions were determined by sieve 
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TABLE I - Composition of granulates
Assay nº Process Material to be granulated Binder (%)
Component % PEG PVP GPS STA GMS
P2 Static Starch 90 10 - - - -
P3 Static Starch 70 30 - - - -
P4 Static Starch 80 20 - - - -
P5 Static Starch 75 25 - - - -
P6 Static Starch 80 20* - - - -
P7 Static Starch 80 - - 20 - -
P8 Static Starch 70 - - 30 - -
P9 Static Starch 70 30 - - - -
P10 Static Starch 70 - - - 30 -
P12 Static Starch 75 - - 25 - -
P13 Static Starch 80 - - - 20 -
P14 Static Starch 75 - - - 25 -
P15 Static Starch 90 - - - 10 -
P20 Moving Starch 75 - - - 25 -
P21 Moving Starch 70 - - 30 - -
P22 Moving Starch 80 20 - - - -
P23 Moving Starch 80 - - 20 - -
P25 Moving Starch 80 - - - 20 -
P30 Moving Starch 70 30 - - - -
P31 Moving Starch 75 25 - - - -
P32 Moving Starch 75 - - - 25 -
P33 Moving Starch 75 - - - - 25
P34 Moving Starch 80 - - - 20 -
P35 Moving Starch 80 - - - - 20
P36 Moving Starch 80 20 - - - -
P37 Moving Starch 70 27 3 - - -
P38 Moving Starch 75 - - - 6.25 18.75
P39 Moving Starch 70 21 9 - - -
P40 Moving CBZ/Starch 60/10 30 - - - -
P41 Moving CBZ/ Lactose 60/15 - - - 6.25 18.75
P43 Moving CBZ/Lactose 60/15 - - - - 25
P44 Moving KP/Starch 30/40 30 - - - -
P45 Moving KP/Starch/ SCC** 30/43/2 25 - - - -
P46 Moving KP/Starch/ SCC** 30/42/3 25 - - - -
P47 Moving KP/Lactose 40/40 - - - - 20
* PEG milled through a 1 mm sieve. ** SCC functions as an intragranular disintegrant.
analysis (Retsch AS 200 control “g”). DIN-ISO 3310/1 
standard sieve series for the static bed process was 125, 
180, 250, 355 and 500 mm; and for the moving bed pro-
cess, 125, 180, 250, 355, 500, 710 and 1000 mm. Particle 
mean size (xm), 10%, 50% and 90% percentiles (x10, x50 
and x90), and span were calculated. Span was calculated by 
the equation: (x90 - x10)/x50. Bulk density was determined 
according to United States Pharmacopeia (USP) <616> 
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and tapped density was determined based on a method 
reported in literature (Fonner, Banker, Swarbrick, 1966). 
Compressibility index was calculated according to USP 
<1174>. Repose angle was determined by means of a 
funnel with a stopper. When the stopper is removed, the 
material flows, and the base and height of the cone-like pile 
formed are measured. Repose angle (a) was calculated by 
the equation: tan (a) = height/(0.5 * base). Friability was 
assayed based on a method reported in literature (Marks, 
Sciarra, 1968), and the percentage of weight loss for the 
resulting granulates was calculated. The average of two de-
terminations was recorded for each of the mentioned tests.
Granulates were compacted (excentric tablet press 
B-MT, J. Bonals, Spain) as a mean of assessing the level of 
success attained regarding the improvement of the physical 
properties required for compaction after granulation by the 
processes proposed in this work, using 9 mm concave or 
12 mm plane round punches. Up to 5% of deviation in the 
tablet weight was accepted. Compacted granulates were 
selected among those which showed acceptable physical 
properties, mainly regarding flow and compactability. As 
required by each formulation, lubricant (0.5% magnesium 
stearate or 1.5% talc) and/or disintegrant (3% sodium 
croscarmellose) was added to the selected granulates in a 
tumbling mixer (Turbula, Bachofen, Switzerland).
The following pharmacotechnical properties of the 
tablets produced were studied: appearance and dimensions, 
weight uniformity, hardness, tensile strength, friability, 
and disintegration time. Friability and disintegration time 
were determined according to USP <1216> and <701>, 
respectively. Hardness and diameter were measured with 
a hardness tester (Erweka TBH 220, Germany). The tablet 
hardness is not a valid parameter for comparing tablets of 
different shape and size. However, if tensile strength is 
calculated by equations, which depend on tablet geometry, 
the influence that the distinct shapes and dimensions might 
have is corrected (Haririan, Newton, 1999).
Multivariate statistical tools
PCA and CA were used to facilitate the evaluation 
of the large number of variables and of the great amount 
of results usually generated during the characterization of 
granulates and tablets.
PCA is used as a dimension reduction tool to sim-
plify a data set, which can only succeed if the original 
variables are correlated (Piggot, 1986). The essential 
information contained in the pharmacotechnical tests 
performed to the granulates and their tablets is revealed 
by PCA, showing trends and relationships for the variables 
as well as for the samples.
In the present work, 35 samples and the following 
11 variables were considered in the PCA of granulates: 
percentage of fines – defined as the fraction of granules 
smaller than 125 µm – (FINES), percentage of granules 
over 500 um for static bed process or 710 um for moving 
bed process (COARSE), mean particle size (MEAN), 10% 
percentile (PERCEN10), 50% percentile (PERCEN50), 
90% percentile (PERCEN90), bulk density (BULK-
DENS), tapped density (TAPDENS), repose angle (RE-
PANG), compressibility index (COMPIND), and granule 
friability (FRIABIL). The variable identified as COARSE, 
which represents the fraction of granules of size over a 
certain limit value, is defined in different ways depending 
on the melt granulation process used. The difference in the 
limit is required due to the characteristics of the granulates 
produced by each process.
Twenty-four samples and the following five varia-
bles were considered in the PCA of tablets: relative stan-
dard deviation of weight (RSDWeight), tensile strength 
(Tstr), relative standard deviation of tensile strength (RS-
DTstr), friability (Friabil), and disintegration time (Disint).
In the present work, PCA was applied on raw data, 
considering correlation between the different variables. 
This selection was based on the fact that the variables were 
measured in different units. Kaiser criterion was applied 
to decide the number of components in the calculation of 
the PCA model.
CA is used to classify samples characterized by a 
series of variables into groups. Ward agglomeration cri-
terion is a standard practice when applying CA in order to 
identify groups of samples of similar size. This procedure 
is usually used with Euclidean distances (Jacobsen, Gun-
derson, 1986). In the present work, CA was applied to the 
original data matrices of granulates and tablets in order 
to study the groups of samples found in the PCA plots. 
Results were graphically depicted under dendrogram form.
All statistical tests were performed using XL-Stat 
2009 (AddinSoft, NY, USA).
RESULTS AND DISCUSSION
PCA of granulates
The first and second principal components (PC1 and 
PC2, respectively) of the granulate data explained 73% 
of the variance of the experimental data. Thus, most of 
the pharmacotechnical information about the granulates 
was provided by only two variables, instead of 11 as in 
the original data.
PC1 explained 57% of total variance and is positive-
ly correlated with coarse fraction, mean particle size and 
percentiles, while negatively with compressibility index 
Application of multivariate techniques in the evaluation of melt granulation products 737
and friability. Meanwhile, PC2 explained 15% of total 
variance and is positively correlated with tapped density. 
Bulk density is negatively correlated with both compo-
nents, while percentage of fines (PC1 loading 0.65, PC2 
loading -0.34) and repose angle (PC1 loading 0.73, PC2 
loading -0.40) are also correlated with both components, 
but positively with PC1 and negatively with PC2.
The following correlations among variables were 
found with PCA: compressibility index correlates inver-
sely with coarse fraction, mean particle size, and 50% and 
90% percentiles, which is reasonable as an increase in 
particle size improves the flow, while also leads to a lower 
compressibility index.
The correlation matrix was performed to confirm the 
correlations among variables which were not so evident 
in PCA. It was observed that compressibility index also 
shows less strong but significant inverse correlation with 
bulk density (r = -0.58; p < 0.01). In addition to improving 
flow, the enlarged size of particles also increases bulk 
density, decreasing compressibility index. Moreover, 
compressibility index directly correlates to repose angle 
(r = 0.62; p < 0.01) and friability (r = 0.56; p < 0.01) in a 
less strong, but significant way. The repose angle directly 
correlates to fines in a not very strong, but significant way 
(r = 0.57; p < 0.01). This correlation is consistent with 
the expected decrease in flow, particularly when particle 
size is not increased after granulation, thus resulting in an 
excess of fines.
Variables and granulate samples were represented 
simultaneously as a biplot diagram in Figure 1. As ob-
served in this plot, PCA showed the granulates divided 
in two distinct groups according to the manufacturing 
process: the granulates obtained by static bed process are 
at the left side, while at the right side are those obtained 
by moving bed process. In PC1 (F1) are the variables 
responsible for the distinction between the granulation 
processes, as percentage of fines and coarse, mean size, 
50% and 90% percentiles, compressibility index, and 
repose angle, whereas in PC2 (F2) are the variables that 
allow the distinction among some granulates, as bulk and 
tapped density. Granulates obtained by static bed process 
show higher percentage of fines, friability, repose angle 
and compressibility index, as well as smaller mean particle 
size and lower percentage of coarse and percentiles, than 
the granulates obtained by the moving bed process.
PCA also revealed other trends. As binder percen-
tage in granulate composition increases in any of the two 
processes, the granulates move towards higher values of 
PC1, which corresponds to a decrease in repose angle, 
compressibility index, friability and percentage of fines, 
and also to an increase in granule mean size, coarse frac-
tion, 50% and 90% percentiles, and, to a lesser extent, in 
10% percentile. The previously mentioned trends are cle-
arly evident for binders PEG, STA, and GMS. In the case 
of STA, since no improvement in binder performance was 
observed by increasing the percentage of binder from 20 
to 30% (granulates P13 and P10, respectively), 30% was 
not further used as granulating concentration with STA.
GPS showed a little erratic behavior by static bed 
process– P12 (25%) located more to the left than P7 (20%), 
while P8 (30%) was located more to the right – and by 
moving bed process – P21 (30%) located more to the left 
than P23 (20%). Possibly, a greater number of assays with 
this binder would allow to elucidate its performance trend. 
However, the results obtained with GPS, i.e., poor impro-
vement in granulate properties as the binder concentration 
is increased and the adhesion problems found during 
compaction, did not generate much expectation over the 
benefit of performing more assays with this binder.
For the binder mixture STA/GMS, which was as-
sayed at 25% w/w of the granulate, the behavior was in 
line with the performance of each separate binder when 
used at the same percentage as the whole mixture.
Last, in the case of the binder mixtures PEG/PVP 
(90%/10% and 70%/30%), which were both assayed at 
30% w/w of the granulate, the increase in fines content 
FIGURE 1 - PCA biplot of granulates for PC1 (F1) and PC2 (F2).
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was noticed as the rate PEG to PVP decreased. The 
behavior of this combination of excipients was in line 
with that of PEG 6000. However, the increase of PVP 
in the mixture at the expense of the decrease of PEG 
weakened the improvements the latter binder had been 
able to achieve in the granulates. These results are not 
in agreement with those reported by Gohel and Jogani in 
their work with PVP K30/PEG 4000 as binder for lactose 
and microcrystalline cellulose mixtures (Gohel, Jogani, 
2003). In the present work, the temperature selected for 
melt granulation is not high enough for povidone fusion; 
therefore, the contribution of the latter excipient to the 
formulation and the process is expected to be accompli-
shed by dissolution in the melted PEG. Although PVP 
K30 is soluble in PEG 6000 in several proportions, its 
dissolution is not fast, as confirmed in preliminary assays. 
It is therefore probable that the melt granulation proces-
ses proposed in the present work do not ensure enough 
contact time among PVP particles and the melted PEG 
in order to allow the complete dissolution.
The granulates are very close regarding PC2, which 
indicates that apparent densities did not increase after 
granulation. Nevertheless, it can be concluded from PCA 
that, for the binder PEG 6000 in moving bed process, den-
sification certainly takes place when the binder percentage 
is increased, as these are the only granulates less grouped 
with respect to PC2, i.e., they showed larger distance in 
the vertical direction (from P36 to P30). In general, PCA 
showed that bulk and tapped densities did not provide 
much information to differentiate either among binders or 
processes, they just helped to differentiate some samples.
Regarding binder initial particle size, PCA con-
firmed what was observed in preliminary studies and 
reported in literature about the relevance of this parameter 
in melt granulation and also about the convenience of 
choosing a small initial particle size for these excipients 
(Schæfer, Mathiesen, 1996). The starch granulate obtained 
with PEG 6000 milled through a 1 mm sieve (P6) was 
located in the upper left of the biplot in Figure 1. When 
P6 coordinates were compared with those of P4 (produ-
ced with PEG 6000 milled through a 0,5 mm sieve), it 
was evident that, with larger binder initial particle size, 
percentage of fines and repose angle were increased and 
50% percentile was decreased.
It was also clear in PCA that the moving bed process 
is the most efficient manufacturing process of the two pre-
sented in this work, as better results in granulate properties 
were obtained with equal percentage of binder and shorter 
processing time.
The trends found for each process were independent 
of the solid material chosen for melt granulation.
CA of granulates
As observed in Figure 2, four clusters or groups of 
samples were found in CA. The classification by manufac-
turing process defines two clusters, but a further division 
in each process is found; therefore, there are four clusters 
in total in the immediate hierarchical level (indicated in 
the plot by a dotted line). Clearly, the first two clusters de-
fined by the manufacturing processes show a significantly 
greater linkage distance than the clusters in the immediate 
level. However, the latter linkage distance is still signifi-
cantly greater than the distances in the following levels; 
moreover, the four finally defined clusters indicate a clear 
division regarding the percentage of binder present in the 
granulate composition.
From left to right, the clusters were formed as 
follows:
First cluster: starch granulates obtained by moving 
bed process with the lowest percentage of each binder, 
plus the granulates of carbamazepine. Thus, this cluster is 
formed by the granulates with the lowest compressibility 
index and friability, low repose angle and percentage of 
fines, and rather high percentage of coarse fraction, mean 
granule size, and 50% and 90% percentiles.
Second cluster: granulates obtained by moving 
bed process with the highest percentage of each binder 
and their mixtures (25% STA/GMS and 30% PEG/PVP 
[27%/3%]), plus the granulates of ketoprofen. This clus-
ter is therefore formed by the granulates with the highest 
percentage of coarse fraction, mean granule size, 50% 
and 90% percentiles, with the lowest repose angle and 
percentage of fines, and with rather low compressibility 
index and friability.
Third cluster: starch granulates obtained by static 
bed process with the highest percentage of each binder, 
plus the granulates obtained by moving bed process with 
FIGURE 2 - Dendrogram of granulates.
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the poorer performances (one with 30% of PEG/PVP 
[21%/9%, mixture with the lower percentage of PEG] and 
another one with 20% of STA). Therefore, this cluster is 
formed by the granulates with rather high repose angle, 
compressibility index, percentage of fines, and friability, 
and also with low percentage of coarse fraction, mean 
granule size and percentiles.
Fourth cluster: granulates obtained by static bed 
process with the lowest percentage of each binder, plus 
the granulates with GPS even at the highest concentration 
(30%). Thus, this cluster is formed by the granulates with 
the highest percentage of fines, repose angle, compressi-
bility index and friability, and with the lowest percentage 
of coarse fraction, mean granule size, and 50% and 90% 
percentiles.
Compaction behavior of granulates
Tablets of proper aspect, mechanical resistance and 
disintegration time, and that comply weight uniformity 
as well as the corresponding assay of active content, 
dose uniformity and dissolution, in the case of tablets 
containing active ingredients, were obtained from several 
granulates.
·	PCA of tablets
The first two principal components (PCs) or factors 
(F) described 68% of the variance of the tablet data. Once 
again, most of the pharmacotechnical information was 
accounted for in the multivariate analysis, indicating that 
it was successful for tablets too.
The loading plot for PCs 1 and 2 (or F1 and F2) for 
each variable, as well as for the tablet samples (score ma-
trix), are represented simultaneously as a biplot diagram in 
Figure 3. PC1 is positively correlated to the disintegration 
time and tensile strength, and negatively correlated to 
friability. PC2 is positively correlated to the relative stan-
dard deviation (RSD) of tensile strength. RDS of weight 
is correlated to both PCs.
The correlations among variables commented he-
reafter were found by means of PCA. Tensile strength 
directly correlates with disintegration time. As in the case 
of granulates, the correlation matrix was done in order to 
confirm the correlations among variables which were not 
so evident in PCA. As a result, it was found that the tensile 
strength inversely correlates with the friability in a not very 
strong, but significant way (r = -0.42; p < 0.05).
As shown in Figure 3, several trends were revealed 
by PCA. As binder percentage in the formulation of a 
granulate obtained by either process is increased, the ta-
blets move towards higher values in PC1, corresponding 
to lower friability, and, to a lesser extent, lower RSD 
of the tensile strength, but also higher tensile strength 
and disintegration time of the tablets. Although a slight 
increase in the RSD of the weight is evident, the results 
are still acceptable, which is consistent with the fact that, 
when the binder percentage is increased, the flow of the 
granulates is improved.
The above mentioned trends are clearly evident for 
the granulating excipients PEG 6000, GPS, and GMS. In 
the case of STA, when concentration is increased from 
20% to 25% (from P34 to P32) practically no changes 
take place, as observed by their proximity in PC1, showing 
the same behavior as the granulates of this excipient. For 
binder mixtures PEG/PVP and STA/GMS, tablets general 
behavior was in line with the results obtained with each 
separate binder when used at the same percentage as the 
whole mixture, following the same trend already observed 
in the granulates. The mixture STA/GMS instead, shows 
better behavior regarding lamination and adhesion to pun-
ch surface than the excipient STA alone (Table II).
As in first instance, different granulates required 
different external phases for compaction, PCA was also 
used to study the effect of the presence or absence of 
magnesium stearate and sodium croscarmellose on the 
compaction behavior of granulates. In every pair of tablets 
formulated with and without these excipients, each tablet 
is very close to its corresponding partner regarding PC1 
(Figure 3). Therefore, PCA contributed to conclude that 
these excipients, when used as lubricant and disintegrant 
respectively, did not affect the results and were after all 
dispensable.
FIGURE 3 - PCA biplot of tablets for PC1 and PC2.
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·	CA of tablets
Five clusters were found in CA (see Figure 4). From 
left to right the clusters were formed as follows:
First cluster: tablets of ketoprofen granulates obtai-
ned by moving bed process with the highest percentage of 
PEG 6000. These are the tablets with the highest tensile 
strength and disintegration time, and the lowest friability.
Second cluster: tablets of ketoprofen granulates with 
low percentage of PEG 6000 and tablets of carbamaze-
pine granulates with PEG 6000 obtained by moving bed 
process. These are tablets with high tensile strength and 
disintegration time, and low friability.
 Third cluster: tablets of starch granulates obtained 
by static bed process with GPS, plus the tablets of granu-
lates obtained by moving bed process with STA and with 
the lowest percentage of GMS. These are the tablets with 
the lowest disintegration time and tensile strength, and 
high friability.
Fourth cluster: tablets of starch granulates obtained 
by static bed process with the highest percentage of PEG 
6000, plus tablets of granulates obtained by moving bed 
process with GPS, PEG 6000 and PEG/PVP. These are the 
tablets with intermediate values of disintegration time and 
tensile strength, and low friability.
Fifth cluster: tablets of starch granulates obtained by 
static bed process with low percentage of PEG 6000, and 
tablets of granulates produced by moving bed process with 
high concentrations of GMS and STA/GMS. These are 
tablets with low disintegration time and tensile strength, 
and high friability.
CONCLUSIONS
PCA showed the trends and relationships among va-
riables and samples, revealed the groupings of granulates 
according to the manufacturing process, as well as the gre-
ater efficiency of the moving bed process, as this process 
provided better results than the static bed process with 
equal percentage of binder and shorter processing time. 
PCA also contributed to conclude about the relevance of 
small binder initial particle size and the use of lubricant 
and disintegrant excipients in formulation steps. Moreo-
ver, PCA allowed the representation of the relationships 
among all variables in only one biplot diagram and it also 
minimized the loss of information, as all variables were 
kept in the analysis.
CA complemented the information generated by 
PCA, supporting the advantage in efficiency of the moving 
bed process over the static one, as well as the influence of 
the concentration of binder employed.
The results regarding the more efficient moving 
bed granulation process, the relevance of binder initial 
particle size in granulation and the use of external phase 
excipients for compaction were found in accordance with 
expectations, showing the ability of this approach to aid 
formulation and manufacturing also in the case of melt 
granulation. Therefore, multivariate statistical methods 
proved to be useful to facilitate the interpretation of the 
obtained data. Hence, it can be concluded that the employ-FIGURE 4 - Dendrogram of tablets.
TABLE II - Compaction behavior of granulates
Granulates Performance in compaction
P14, P14-FE Uniform flow, excessive adhesion to punch surface
P21, P32, P32-FE, P34, P35 Uniform flow, lamination, adhesion to punch surface
P7, P8 Uniform flow, lamination
P33, P33-FE, P38 Uniform flow, tendency to laminate and adhere to punch
P4, P5 Uniform flow, tendency to laminate
P45, P46 Uniform flow, tendency to adhere to punch surface
P3, P9, P30, P30+FE, P31, P36, P37, P40, P44 Smooth surfaces, uniform flow, good compactability
-FE: without external phase
+FE: with magnesium stearate as external phase
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ment of PCA and CA optimize the study of the properties 
of melt granulates and tablets, and the selection of more 
efficient production processes.
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